CAMBRIDGE, Mass., July 29 (UPI) -- A portable device may allow doctors to create single doses of biopharmaceutical medications on demand, potentially speeding the treatment of diseases that include diabetes and cancer.
The portable production system was developed by scientists at the Massachusetts Institute of Technology, with funding from the U.S. Defense Advanced Research Projects Agency, expecting the device could be useful for the battlefield and remote areas to produce treatments immediately at the point of care.
Biopharmaceutical manufacturing generally requires single biologic-producing cell lines cultivated at large scales, making treatment with these types of drugs difficult in short time frames.
